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I. INTRODUCTION
Genetic engineering is changing the semantics, the meaning of
life itself We're trying to usurp the plant's choice. To force alien
words into the plant's poem, but we [have] a problem. We barely
know the root language. Genetic grammar's a mystery ....
We've learned a lot about the letters-maybe our ability to read
and spell words now sits halfway between accident and design-
* Debra Strauss is an Assistant Professor of Business Law at Fairfield Univer-
sity, Charles F. Dolan School of Business. She received her B.A. from Cornell Uni-
versity and her J.D. from Yale Law School. Professor Strauss, a former Food and
Drug Law Institute Scholar, currently teaches the legal environment of business,
international law, and law and ethics.
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but our syntax is still haphazard. Scrambled. It's a semiotic
nightmare.
Man alone of all Nature's children thinks of himself as the center
about which his world, little or large, revolves, but if he persists in
this hallucination he is certain to receive a shock that will waken
him or else he will come to grief in the end.!
One of the essential functions of life is the ability to reproduce
for the survival of future generations. The biotechnology industry is
taking this ability away in order to turn a profit for no other reason
than because they can-man has figured out the essence of life.
Genetically Modified Organisms (GMOs) are created when the
genes of one organism are inserted into the DNA of another organ-
ism, causing the target trait to be expressed in that non-related spe-
cies.' The genetically modified (GM) plants then produce GM foods
and ingredients, which now occupy a vast majority of food products
on U.S. grocery store shelves.4 Glyphosate-tolerant soybeans (e.g.,
Roundup Ready® by Monsanto) contain a gene that protects them
from the herbicide glyphosate, allowing the fields to be sprayed with
the herbicide to kill the weeds while leaving the soybeans standing.'
Herbicide-resistant varieties of canola, cotton, corn, radicchio, rice,
and sugar beet are also on the market.6 Genes derived from a bacte-
rium in the soil used as an insecticide, Bacillus thuringiensis (Bt), have
been inserted into crops to induce the plant to produce a toxin
against certain insects, producing Bt-corn, Bt-cotton, Bt-potatoes, Bt-
rice, and Bt-tomatoes.7 The United States has approved virus-
1. RUTH OZEKI, ALL OVER CREATION 124-25 (Penguin Books 2003).
2. Id. at 243 (quoting LUTHER BURBANK & WILBUR HALL, THE HARVEST OF THE
YEARs (1927); Luther Burbank was a pioneer of agricultural science who, among
other things, developed the Burbank potato).
3. See Associated Press, Americans Clueless About Gene-Altered Foods (Mar. 24,
2005), available at http://pewagbiotech.org/newsroom/summaries/dis-
play.php3?NewsID=857.
4. The Grocery Manufacturers of America estimates that seventy-five percent of
all processed foods in the United States contain a GM ingredient, including almost
every product with a corn or soy ingredient and some containing canola or cotton-
seed oil. See id. (statement of Stephanie Childs, Grocery Manufacturers of Amer-
ica).
5. See Food & Drug Administration (FDA), Center for Food Safety & Applied
Nutrition (CFSAN), List of Completed Consultations on Bioengineered Foods (Nov.
2005), available at http://www.cfsan.fda.gov//-Ird/biocon.html.
6. See id.
7. See id. "Bacillus thuringiensis (Bt) is a naturally occurring soil bacterium that
produces proteins active against certain insects." Mike Mendelsohn et al., Are Bt
Crops Safe?, 21 NATURE BIOTECHNOLOGY 1003 (Sept. 2003).
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resistant varieties of papaya, potato, and squash, along with tomato
and cantaloupe varieties containing a gene that slows the ripening
process to allow fruit to ripen longer on the vine.' There is even an
invention called "Terminator" technology, also known as Genetic
Use Restriction Technologies (GURTs), which refers to plants that
have been genetically modified to render sterile seeds at harvest,
eliminating the possibility of future generations from a plant's
seeds.9 Terminator technology was developed by the multinational
seed/agrochemical industry and the United States Department of
Agriculture (USDA) to prevent farmers from saving and replanting
harvested seed.'" Terminator technology has not yet been commer-
cialized or field-tested, but tests are currently being conducted in
greenhouses in the United States."
Unlike the strict regulatory approach of European and interna-
tional law, the United States does not treat genetically modified
foods differently than other foods.'" Since the development of GM
foods, no federal legislation has been enacted, nor have regulatory
agencies required any labeling or special approval of these sub-
stances." The legal system in the United States appears to be ill-
equipped or unwilling to recognize the risks (i.e., the Food and
Drug Administration (FDA) does not consider genetically engi-
8. See id.
9. Ban Terminator, Genetic Use Restriction Technologies (GURTs),
http://www.banterminator.org/glossary/genetic use-restriction-technologies
_gurts (last visited Aug. 18, 2007).
10. CANADIAN INST. FOR ENVTL. L. & POL'Y, FACT SHEET SERIES ON INNOVATIVE
TECHNOLOGIES-2006: GENETIC USE RESTRICTION TECHNOLOGIES (GURTs) OR
TERMINATOR TECHNOLOGY, at 3 (2006), available at http://www.cielap.org/
pdf/TerminatorTechnologyFactsheet.pdf.
11. "Genetic Use Restriction Technologies (GURTs) is the 'official' name for
Terminator technology that is used at the United Nations and by scientists. It re-
fers to ... technologies that, in their design, provide a mechanism to switch intro-
duced genes on or off, using external inducers like chemicals or physical stimuli
(e.g., heat shock). This mechanism allows for restricted use or performance of
transgenes." See Ban Terminator, supra note 9. Two types of GURTs rely on the
same mechanism: variety-related (V-GURTs) and trait-related (T-GURTs). V-
GURTs control reproductive processes to result in seed sterility, thus affecting the
viability of the whole variety. T-GURTs control the use of traits such as insect resis-
tance, stress tolerance or production of nutrients. See id.
12. See Debra M. Strauss, The International Regulation of Genetically Modified Or-
ganisms: Importing Caution into the U.S. Food Supply, 61 FOOD & DRUG L.J. 167, 168
(2006) [hereinafter International Regulation of Genetically Modified Organisms] (dis-
cussing the legal issues associated with the regulation of GMOs, including a com-
parison of European and international law to the U.S. approach and a proposal for
labeling and monitoring).
13. Id. at 182.
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neered foods to be a "substantially different" product or a "mate-
rial" change from other hybrid methods)'4 and regulate this area.'5
Perhaps this is another area where an examination of the ethical
issues can lead to developments in the law-the arguments have to
be raised for the community to address the concerns and resolve
these issues.
Meanwhile, the proliferation of GM crops continues. "Global
biotech crop acreage grew to 252 million acres in 2006, according to
the International Service for the Acquisition of Agri-biotech Appli-
cations (ISAAA)."" Since biotech crops were first commercialized in
1996, the global biotech crop area has increased more than fifty-
fold; most astonishingly, the one-billionth cumulative acre of biotech
crops was planted in 2005.'" These GM crops were planted in
twenty-two countries by 10.3 million farmers.'8 Of the 10.3 million
farmers, ninety percent are resource-poor farmers in developing
countries, and developing countries comprise more than one-third
of the global biotech crop acreage." However, the United States
leads in total crop acreage-49.8 million hectares (fifty-five percent
of the global biotech area)-with the biotech crops of soybean,
maize, cotton, canola, squash, and papaya."° Biotech soybean was
the principal biotech crop in 2005, occupying 54.4 million hectares
(sixty percent of global biotech area), followed by maize (21.2 mil-
lion hectares at twenty-four percent), cotton (9.8 million hectares at
eleven percent) and canola (4.6 million hectares at five percent).'
Between 1996 and 2005, the first decade of commercialization of
GM crops, the dominant trait introduced into crops was herbicide
14. Id. at 183.
15. Id. at 168.
16. Biotechnology Industry Organization (BIO), 2006 Global Biotech Crop Acreage
Increases by 13 Percent Over 2005, http://www.bio.org/news/features/
20060210.asp?p=yes (last visited Aug. 18, 2007).
17. See Truth About Trade & Technology, One Billionth Acre of Biotech Crops Has
Been Planted, http://www.truthabouttrade.org/article.asp?id=3833 (last visited Aug.
18, 2007).
18. See BIO, supra note 16.
19. See id. See also Truth About Trade & Technology, supra note 17.
20. CLIVEJAMES, INT'L SERV. FOR THE ACQUISITION OF AGRI-BIOTECH APPLICATIONS
(ISAAA), ISAAA BRIEFS No. 34-2005: EXECUTIVE SUMMARY: GLOBAL STATUS OF
COMMERCIALIZED BIOTECH/GM CROPS: 2005, at iii, available at http://
www.isaaa.org/Resources/publications/briefs/34/download/isaaa-brief-34-
2005.pdf.
21. Id. at iv.
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tolerance, followed by insect resistance and stacked genes for the
two traits.'
This growth has led the industry to proclaim that "agricultural
biotechnology has been adopted faster than any other farming im-
provement since introduction of the tractor in the 1800's."' A small
number of powerful companies own large percentages of the world
seed market, consolidating their seeds and agricultural chemical
operations through buy-outs and licensing of technology.24 "Mon-
santo's role as probably the most incessant promoter of genetic en-
gineering in agriculture has been bolstered by its acquisitions of
many of the largest, most established seed companies in the U.S."'
Monsanto is publicly touting bringing to the market their "second
generation traits" and their "commercial head start is helping [Mon-
santo] move new products through pipeline development to market
faster."" In fact, some say that transgenic crops have been devel-
oped, introduced, and adopted quickly in the United States, perhaps
in part because approval is cheaper and faster than the approval
process for a new chemical pesticide.' With its focus on marketing,
speed, and market share, this biotechnology company clearly sounds
like the big business that it is, rather than a scientific organization
that gives greater consideration to public policy and safety concerns.
22. Id.
23. Monsanto, Learn About Agricultural Biotechnology, http://www.monsanto.
com/monsanto/layout/feature02.asp (last visited Aug. 18, 2007).
24. See, e.g., Delta and Pine Land Company (DPL), D&PL Investor News,
http://www.deltaandpine.com/press-investors.asp (last visited Aug. 18, 2007).
This U.S.-based transnational "seed giant that vows to commercialize Terminator
seed technology is expanding its global reach with the recent acquisition of Syn-
genta's global cotton seed business. The new acquisition gives Delta & Pine Land's
cotton seed business a bigger stake in India, Brazil, and Europe. The company is
the world's leading cotton seed company. In 2005, DPL had revenues of $366 mil-
lion." See Ban Terminator, Delta & Pine Land, developer of Terminator seeds, extends
global reach, May 22, 2006, http://www.banterminator.org/news-up-
dates/newsupdates/delta-pinejland-developer of terminator seeds extends-glo
balreach (last visited Aug. 18, 2007).
25. Brian Tokar, Resisting Biotechnology and the Commodification of Life, 18
SYNTHESIS/REGENERATION, Winter 1999, available at http://www.greens.org/s-
r/18/18-01.html.
26. Monsanto, Products and Solutions, Setting the Standard in the Field,
http://www.monsanto.com/monsanto/layout/products/default.asp (last visited
Aug. 18, 2007).
27. DAVID E. ERVIN ET AL., HENRY A. WALLACE CTR. FOR AGRIC. & ENV'T POLICY AT
WINROK INT'L, TRANSGENIC CROPS: AN ENVIRONMENTAL ASSESSMENT 14 (Nov. 2000),
available at http://www.winrock.org/wallace/wallacecenter/documents/trans-
genic.pdf.
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These facts raise key queries: Do we trust companies like Monsanto
to make these significant decisions about the future of our food
supply? Given their inherent focus on profit, are they the appropri-
ate parties to make ethical determinations about where our re-
sources and technology should be directed? 8
A recent survey on GM foods revealed that a significant major-
ity of consumers believe that the government should include ethical
and moral considerations when making regulatory decisions about
genetic engineering.' Moreover, consumers "seek an active role
from regulators to ensure that new products are safe. "'° In making
these decisions about the public health, participation of all stake-
holders is essential.
In view of the mandate from consumers and the critical role of
food safety in human health and the environment, more reflective
thought must be given to the direction of biotechnology in the fu-
ture. Part II of this article will analyze the promise of this technol-
ogy to see whether it has fulfilled its purported goals of reducing
world hunger, decreasing pesticide use, improving nutritional con-
tent, and increasing farmers' income. It will then contrast these re-
sults with the potential risks of GM plants and GMOs in the food
supply. In Part III, this article will examine some of the key ethical
issues arising from genetic engineering: respect for nature and the
value of life; consideration of the environment; rights and responsi-
bilities; equity, power, and the economically disadvantaged; and
conflicts of interest in public research. Part IV will present a pro-
posal that takes into account these ethical concerns and, accord-
ingly, advocates involving all stakeholders, including farmers, con-
sumers, the environment, and underprivileged populations, as well
as the biotechnology industry; educating the public on the science
and risks; requiring comprehensive labeling to enable informed
consumer choice; and promoting a more active and independent
role for government agencies in regulating biotechnology compa-
nies. Part V will conclude with an exploration of some questions
that would aid policymakers in implementing a new regulatory
scheme in the United States, including comparisons to the approach
28. See generally HELENA PAUL & RICARDA STEINBRECHER, HUNGRY CORPORATIONS:
TRANSNATIONAL BIOTECH COMPANIES COLONISE THE FOOD CHAIN (2003).
29. See The Melman Group, Memorandum to the Pew Initiative on Food & Bio-
technology, at 7, available at http://pewagbiotech.org/research/2005update/
2005summary.pdf.
30. See generally Pew Initiative on Food & Biotechnology, Public Sentiment About
Genetically Modified Food (Nov. 2005), available at http://pewagbiotech.org/re-
search/2005update/.
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taken by the international community. An incorporation of ethical
issues into U.S. law would call for the government to fulfill its re-
sponsibility to protect its citizens, respond to their concerns, and
not betray their trust by compelling them to bear the risks of GMOs
without informed consent. This article will also consider global in-
terests such as the disparities in natural resources and technical ex-
pertise between the United States and economically developing
countries, and urge that biotechnology not be used to divert impor-
tant resources from the research and application of more sustain-
able solutions for world food security.
II. THE FAILED PROMISE
The promoters of biotechnology in agriculture promised great
benefits of genetically engineered crops. A study commissioned by
the World Health Organization (WHO) cited several expected bene-
fits of this food technology, including the potential for increased
agricultural productivity and improved nutritional values, along with
"reduced agricultural chemical usage and enhanced farm income,
and improved crop sustainability and food security, particularly in
developing countries."3 Supporters tout the goals of reducing hun-
ger by increasing food productivity, conserving the environment by
reducing pesticide and herbicide use, enhancing nutritional content,
and improving food quality."
However, the same study found that many of these goals have
not been met." "Some [farmers] report lower yields, continuing
dependency on chemical sprays, loss of exports, and critically re-
duced profits for farmers as a consequence of using biotechnol-
ogy.' A closer look at each of the claimed benefits reveals that the
promise of this technology has not been realized. In fact, the poten-
tial risks may far outweigh any expected benefits.
31. World Health Organization (WHO), Modern Food Biotechnology, Human
Health and Development: an Evidence-Based Study, at iii (June 24, 2005) [hereinafter
WHO Study], available at http://www.who.int/foodsafety/publications/biotech/
biotech en.pdf.
32. See, e.g., Tzu-Ming Pan, Current Status and Detection of Genetically Modified
Organism, 10J. FOOD & DRUG ANALYSIS 229, 230 (2002).
33. WHO Study, supra note 31, at 53-55.
34. Id. at 53; see also Press Release, Soil Association, GM crops increase chemical
use by 70 million pounds (Jan. 13, 2004), available at http://
www.soilassociationscodland.org/web/sa/saweb.nsf/848d689047cb466780256a6b0
0298980/4111f557521ae02680256e1a005eba55!OpenDocument.
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A. The Reduction of World Hunger
Despite its noble goals to increase the food supply on the
planet, the technology has not been applied in that direction. So
far, the large yield increases, which had been anticipated from crops
such as engineered Bt-corn and cotton, have not been documented.5
Experimental trials now indicate that genetically engineered seeds
do not increase crop yields.' Moreover, genetically modified (GM)
products currently on the market appear to benefit seed companies
and some large farmers, rather than offering higher quality or lower
prices to consumers."
Fundamentally, the notion that GM crops hold the solution to
world hunger misconceives and oversimplifies the problem, which is
not due to a lack of food. Experts affirm that enough food exists to
feed the world population and that the hunger problem is due to a
lack of access, distribution, and sustainability of practices.' In de-
nouncing the view that hunger is due to a gap between food produc-
tion and human population growth, others point to poverty, ine-
quality, and lack of access to food and land as the real causes." The
use of this technology cannot be effective as a quick fix for a larger
social problem.
There are suggestions that the use of biotechnology in agricul-
ture may even worsen the situation by diverting attention and re-
sources from the real issues and solutions. Studies show that much
of the needed food can be produced by small farmers located
throughout the world using agroecological technologies." Farmers
35. Margaret Rosso Grossman, Biotechnology, Property Rights and the Environment,
50 AM.J. COMP. L. 215, 218 (Supp. 2002) (outlining the risks and benefits associated
with GM foods); ERVIN, supra note 27, at 20-21, 30.
36. Miguel A. Altieri & Peter Rosset, Ten Reasons Why Biotechnology Will Not
Ensure Food Security, Protect the Environment and Reduce Poverty in the Developing
World, 2 AGBIoFORUM 155, 156 (1999), available at
http://www.agbioforum.org/v2n34/v2n34a03-altieri.pdf.
37. See Grossman, supra note 35; see also John Hodges, The Genetically Modified
Food Muddle, 62 LIVEsTOCK PROD. Sci. 51, 52 (Dec. 1999).
38. Sophia Kolehmainen, Precaution before Profits: An Overview of Issues in Geneti-
cally Engineered Food and Crops, 20 VA. EVNTL. L.J. 267, 286 (2001) (Director of Pro-
grams at the Council for Responsible Genetics discussing risks of GMOs to human
health and environment).
39. Altieri & Rosset, supra note 36.
40. Norman Uphoff & Miguel Altieri, Alternatives to Conventional Modern Agricul-
ture for Meeting World Food Needs in the Next Century (Report of a Bellagio Confer-
ence, Cornell International Institute for Food, Agriculture and Development)
(1999), available at http://rodaleinstitute.org/international/conference/bella-
gio.pdf.
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and non-governmental organizations initiating new rural develop-
ment approaches and low-input technologies are making progress in
securing food sustainability at the household, national, and regional
levels in Africa, Asia, and Latin America." Supporting GM technol-
ogy may actually hamper these efforts, in that "[flailure to promote
such people-centered agricultural research and development due to
the diversion of funds and expertise towards biotechnology will
forego an historical opportunity to raise agricultural productivity in
economically viable, environmentally benign, and socially uplifting
ways. "4 Most significantly, these alternate, arguably preferable
methods do not carry the same risks to human health and the envi-
ronment that are involved with the use of biotechnology. In con-
trast, any promise to end world hunger has been thwarted as the
companies have utilized this technology to produce Terminator
seeds, so that the farmers and poor nations are forced to buy the
seeds every year and change the traditional ways of farming.3 To
make matters worse, the Terminator gene can spread to the farm-
ers' other crops through cross-pollination, contaminating them and
effectively condemning all future generations of these plants to a
death sentence." The security of the world's food supply has never
been more precarious."
B. The Reduction of Pesticide Usage
As part of its pledge, Monsanto promises to "use sound and in-
novative science and thoughtful and effective stewardship to deliver
high-quality products that are beneficial to [its] customers and to the
environment."' Contrary to its marketing materials which promise
farmers that they will reduce pesticide use or chemical inputs, the
41. Altieri & Rosset, supra note 36, at 159 (citing JULES PRETTY, REGENERATING




44. See Martha L. Crouch, How the Terminator Terminates: An Explanation for the
Non-Scientist of a Remarkable Patent for Killing Second Generation Seeds of Crop Plants,
18 SYTHESIS/REGENERATION (1999) (explaining the patent for killing second genera-
tion seeds of crop plants and the environmental risks involved).
45. See Ricarda A. Steinbrecher & Pat Roy Mooney, Terminator Technology: The
Threat to World Food Security, 28 THE ECOLOGIST 276 (1998), available at
http://www.orpheusweb.co.uk/john.rose/ttech.html.
46. Monsanto, Our Pledge, http://www.monsanto.com/monsanto/layout/our_
pledge/monsantopledge.asp (last visited Aug. 18, 2007).
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herbicide resistant plants may in fact do the opposite." Instead of
applying pesticides sparingly, farmers can spray even more toxic
chemicals on the plants because they are not concerned about kill-
ing the GM crops as they would be with non-genetically engineered
varieties. " Moreover, this GM product may increase pesticide use
even further in the future with the inevitable development of herbi-
cide resistant weeds.49 One expert has predicted that "[a]lthough in
a few instances [herbicide-resistant crops] may result in a reduction
of toxic herbicide use, it is more likely that the use of herbicide-
resistant crops will increase herbicide use and environmental pollu-
tion."0 In addition, he notes that "farmers will suffer because of the
high costs of employing herbicide-resistant crops [particularly since
herbicide-resistant crops] may increase weed control costs two-
fold.""5
The profit motive of the biotechnology companies is obvious, as
they also own the companies supplying the chemicals. The names
of the products themselves clearly indicate this connection, for ex-
ample, Monsanto's Roundup® pesticide to be used with Monsanto's
Roundup Ready® (Roundup® resistant) plants." It is not surpris-
ing, then, that "more than forty percent of the research conducted
by biotechnology firms focuses on the development of herbicide-
resistant crops."' If the use of these crops increases sales of pesti-
cides, these companies raise their revenue exponentially. Juxta-
posed in Monsanto's promotional materials is a statement of its re-
cord sales of $5.95 billion in the first three quarters of 2006, which
Monsanto attributes primarily to its seed and traits business and
47. Institute of Science, Technology, and Public Policy, Genetic Engineering: A
Cautionary Approach (Feb. 13, 2001), http://www.istpp.org/genetic-engineer-
ing.html (last visited Aug. 22, 2007).
48. Id.
49. Id. "Some scientists estimate that not only will herbicide use triple as a result
of herbicide resistant crops, but will ultimately give rise to herbicide resistant weeds
as well." Id.
50. David Pimentel, Overview of the Use of Genetically Modified Organisms and Pesti-
cides in Agriculture, 9 IND.J. GLOBAL LEGAL STUD. 51, 63 (2001) (a study by a Profes-
sor of Ecology and Agricultural Science at Cornell University of the effect of GMOs
on pesticide use in agriculture).
51. Id.
52. Altieri & Rosset, supra note 36.
53. Id.
54. Pimentel, supra note 50.
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higher sales of Roundup herbicides in the United States and Argen-
tina."
In addition, even plants that are genetically engineered for pest
resistance, such as Bt crops, may need the application of pesticides.
When farmers plant Bt-engineered crops that kill their target preda-
tors, they still need to spray their fields to control other insects that
are resistant to Bt.' Moreover, these pest-resistant varieties may
trigger the creation of Bt-resistant "super bugs." 7 Bt crops violate
the widely accepted principle of integrated pest management
(IPM)-that reliance on any single pest management technology
tends to trigger shifts in pest species or the evolution of resistance
through one or more mechanisms. 8
It should also be noted that as the effectiveness of Bt as a pesti-
cide is ultimately reduced by this extreme overuse, the organic
farmer will be further impacted. Currently, Bt is one of the only
resources available to organic farmers, who use it in small quantities
in its original form as a natural pesticide. The insertion of the Bt
gene directly into the cells of these plants may render useless the
natural Bt pesticide that is relied upon by organic farmers and oth-
ers desiring to reduce chemical dependence.'
Theoretically at least, the use of engineered plants in sustain-
able and integrated agriculture should reduce pesticide use, but this
is not the current trend. "The current products--especially herbi-
cide-resistant crops and Bt-resistant crops-have serious environ-
mental impacts."6' These facts, combined with the risks associated
with GMOs and the greater threat that GM crops pose to the or-
ganic farming industry, reveal that the use of genetics to control
weeds and pests in this situation may not be as beneficial as
55. Monsanto, Seed and Traits Business Drives Record Third-Quarter Sales: U.S. corn
seed and traits business sees continued market share gains, broader adoption of stacked corn
traits, http://monsanto.mediaroom.com/index.php?s=43&item=17 (last visited
Aug. 18, 2007).
56. See Andy Coghlan & Barry Fox, Keep that Spray: Crops Made Resistant to Pests
Still do Better With Chemicals, NEW SCIENTIST, Dec. 18, 1999, at 5 (explaining that
Novartis patent applications indicate that farmers may need to use more pesticides
to get the most out of GM plants).
57. Id.
58. See NATIONAL RESEARCH COUNCIL, NATIONAL ACADEMY OF SCIENCES,
ECOLOGICALLY BASED PEST MANAGEMENT (1996).
59. Altieri & Rosset, supra note 36, at 157 (citing James Mallet & Patrick Porter,
Preventing insect adaptations to insect resistant crops: are seed mixtures or refugia the best
strategy? 250 PRO. ROYAL Soc'Y LONDON B 165 (1992)).
60. Id.
61. Pimentel, supra note 50, at 64.
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claimed." Moreover, a fundamental ethical question resounds: is it
a noble end of man to use biotechnology to cause plants to be resis-
tant to insecticides, so that whenever stronger pesticides are sprayed
on the fields, only these resistant plants are left standing?
C. The Improvement of Nutritional Content
In answer to the question of whether GMOs are the best way to
ensure nutritionally adequate food, one expert responds "no," ex-
plaining that "food insecurity is a problem of inadequate access, and
GMOs promise to do little to remedy that problem.""2 The com-
mercial interests that dominate the developments in Genetically
Modified Organisms (GMOs) perceive "too little financial return to
develop products targeted towards poor, malnourished populations"
who would be the most likely beneficiaries of vitamin or mineral-
rich grains. ' Moreover, the focus on GMOs and public investments
in biotechnologies for developing countries diverts research and
development from the "agroecological, people-centered approaches
that are more likely to benefit small-scale producers in the short and
long term."' Citing this "clash between monocrop, high-tech seed,
cash chemical-intensive agriculture on the one hand, and diversified,
farmer-controlled, management-intensive agriculture on the other,"
the author concludes that "the best way to make new technologies
serve the people is by having more control over these technologies
in the public sector." '
In an apparent response to these criticisms, the biotech indus-
try has recently focused its marketing campaign on the production
of rice that is genetically fortified with vitamin A, called "Golden
Rice."67 This genetically engineered rice produces beta-carotene in
its endosperm, giving it a distinct yellow color. The industry claims
that Golden Rice will aid people in developing countries who lack
vitamin A in their diets.' Critics of the biotechnology industry,
62. See, e.g., Kolehmainen, supra note 38, at 285-86.
63. Ellen Messer, Food Systems and Dietary Perspective: Are Genetically Modified
Organisms the Best Way to Ensure Nutritionally Adequate Food?, 9 IND.J. GLOBAL LEGAL
STUD. 65, 89 (2001).
64. Id. at 67.
65. Id. at 88.
66. Id. at 87.
67. Kolehmainen, supra note 38, at 286.
68. See id. See also Trisha Gura, New Genes Boost Rice Nutrients, 285 ScI. 98
(1999); Press Release, GE Food Alert, Monsanto Joins First Lady's Vitamin A Out-
reach Efforts: Beta Carotene Technology Offered to Developing World Farmers
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however, cite the use of genetic engineering technology as another
example of a "quick techno-fix to a larger, more complex prob-
lem."69 They say that such GM products will not end vitamin A defi-
ciencies because a paucity of a single micronutrient like vitamin A
"seldom occurs in isolation, but is one aspect of a larger context of
deprivation and multiple nutrient deficiencies."7" In other words,
people suffer from vitamin A deficiency, not because their rice con-
tains too little vitamin A or beta-carotene, but because of a lack of
variety in their diet, and they suffer many other dietary illnesses that
cannot be addressed by beta-carotene.' "A magic-bullet solution
that places beta-carotene into rice-with potential health and eco-
logical hazards-while leaving poverty, poor diets, and extensive
monoculture intact is unlikely to make any durable contribution to
well-being."'
Furthermore, this situation presents as much a social problem
in that "the obstacles of access and distribution," as with non-GE
rice, "must still be overcome to get the rice to those who need it."7'
There may also be cultural barriers; in the past, non-white grains
have not been accepted by some societies. The Rural Advance-
ment Foundation International (RAFI)75 has suggested other "low-
tech and more cost-effective initiatives, [including the planting of]
many vitamin-rich food plants that were once cheap and available."76
This organization argues that, "[r]ather than nurture a strategy that
encourages biodiversity, golden rice could promote monocultures
(March 16, 1999), http://www.gefoodalert.org/News/news.cfm?NewsID=165 (last
visited Aug. 20, 2007).
69. Kolehmainen, supra note 38, at 286.
70. Genetic Res. Action Int'l, Engineering Solutions to Malnutrition (March 2000),
http://www.grain.org/publications/reports/malnutrition.htm (last visited Aug. 18,
2007).
71. Peter M. Rosset, Transgenic Crops to Address Third World Hunger? A Critical
Analysis, 25 BULL. OF ScI. TECH. & Soc'Y 306, 310 (2005), available at
http://www.landaction.org/gallery/RossetGMhunger.pdf.
72. Id.
73. Kolehmainen, supra note 38, at 287.
74. Id. at 286-87.
75. RAFI, now called the Action Group on Erosion, Technology and Concentra-
tion (ETC group), is an organization "dedicated to the conservation and sustainable
advancement of cultural and ecological diversity and human rights." See ETC, About
ETC Group, http://www.etcgroup.org/en/about/ (last visited Aug, 17, 2007).
76. RAFI, ON GOLDEN PAwNS: THE GOLDEN RICE DEAL-Do THE POOR GET
UNPROVEN GM RICE WHILE ASTRAZENECA GETS THE GOLD? (June 20, 2000), available
at http://www.etcgroup.org/upload/publication/319/01/geno-ongolden.pdf.
JOURNAL OF FOOD LAW & POLICY
and genetic uniformity. This is the wrong strategy."77  Thus, al-
though the use of this technology in this manner provides good pub-
licity for the industry, it may not be able to fulfill its promises.
D. The Increase in Farmers' Income
Results on farmer profitability have been mixed, at best. A
United States Department of Agriculture (USDA) report on the
economic consequences of GM crops summarized a positive impact
of the adoption of Bt-cotton on net farm returns, but a negative im-
pact in the case of Bt-maize.7" "An improvement of returns has also
been seen with herbicide-tolerant maize, whereas no significant im-
pacts were observed with herbicide-resistant soybean." 9 A study by
the European Commission on the economic impact of GM crops on
agriculture found that "a quick adoption by farmers in the United
States was the result of strong profitability expectations" but "there
was no conclusive evidence on farm-level profitability of GM
crops."8" In addition, a report by the Soil Association found that
farmers are not achieving the higher profits promised by the bio-
technology companies due to the collapse of markets for GM foods
and widespread GM contamination.'
The WHO study determined that the cost-efficiency of GM
crops appears to vary with the specific situations, such as growth
conditions that are dependent on regional agro-ecological factors,
particularly the baseline of pest pressure and pesticide uses.7 As a
consequence, the study concluded that in certain situations "other
77. Justin Gillis, Monsanto offers patent waiver on 'Golden Rice,' WASH. POST, Al,
Sept. 30, 2000, available at http://www.grain.org/bio-ipr/?id=175.
78. WHO Study, supra note 31, at 53.
79. Id. (citing JORGE FERNANDEZ-CORNEJO & WILLIAM MCBRIDE, U.S. DEPT. OF
AGRIC., GENETICALLY ENGINEERED CROPS FOR PEST MANAGEMENT IN US
AGRICULTURE, AGRIC. ECON. REP. No. AER786 (May 2000), available at
http://www.ers.usda.gov/publications/AER786/).
80. Id. at 53-54 (citing EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR
AGRICULTURE, ECONOMIC IMPACTS OF GENETICALLY MODIFIED CROPS ON THE AGRI-
FOOD SECTOR (Working Document), available at http://europa.eu.intV
comm/agriculture/publi/gmo/ch3.htm).
81. "The Soil Association estimates that GM soya, maize, and oilseed rape could
have cost the U.S. economy $12 billion since 1999 in farm subsidies, lower crop
prices, loss of major export orders and product recalls." Press Release, Soil Asso-
ciation, GM crops are economic disaster shows new report (June 5, 2003), available
at http://www.soilassociation.org/web/sa/saweb.nsf/848d689047cb466780256a6b
00298980/80256ad80055454980256c320058c60e!OpenDocument.
82. WHO Study, supra note 31, at 54.
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practices for planting may be more valuable because of various re-
gional or market-related reasons."83 In fact, in some countries pro-
hibiting the planting of GM crops would give the region a marketing
edge by guaranteeing that none of its food exports contain GM
crops?' In other countries, potentially expensive efforts to segregate
GM crops from crops of conventional or organic farming include
specific isolation distances, buffer zones, pollen barriers, control of
volunteer plants, crop rotation, and planting arrangements for dif-
ferent flowering periods, as well as monitoring during cultivation,
harvest, storage, transport, and processing. Moreover, the WHO
study identified additional costs from the issues of liability and
compensation for economic loss due to contamination.'
As a means of decreasing poverty in developing countries, GM
crops do not appear promising. A study of global hunger data ana-
lyzed the constraints affecting the productivity of small farmers in
the third world and found that in impoverished nations, people are
too poor to buy the food that is available (but often poorly distrib-
uted) or lack the land and resources to grow it themselves; in fact,
overproduction-and consequent low crop prices-is one of the most
persistent problems generating poverty (and thus hunger) in rural
areas.' Rather than helping the situation, GM crops could have the
opposite effect because "[a]n examination of the special risks these
varieties pose for poor farmers in the complex, diverse, and risk-
prone environments that characterize peasant agriculture on a
global scale suggests that transgenic crop varieties are likely to be
more of hindrance than a help to the advancement of poor farm-
ers."87 In particular, the environmental risks would be heightened
for the vulnerable peasant farmers; cross-contamination could cause
the loss of the locally adapted varieties that they depend on and the
biodiversity critical for world food security.
83. Id.
84. Id. (citing NUFFIELD COUNCIL ON BIOETHICS, THE USE OF GM CROPS IN
DEVELOPING COUNTRIES (1999), available at http://www.nuffieldbioethics.org/
go/browseablepublications/gmcropsdevcountries/report_153.html; Hans van Meijl
& Frank van Tongeren, Agric. Econ. Res. Inst., International diffusion of gains from
biotechnology and the European Union's Common Agricultural Policy (2002), available at
http://www.cepr.org.uk/meets/wkcn/6/ 6608/papers/tongeren.pdf; and Novis,
Economy to benefit from GMfree zones? (Dec. 22, 2003), http://
www.foodnavigator.com/news/ng.asp?id=48708 (last visited Aug. 21, 2007)).
85. Id. at 53.
86. See generally Rosset, supra note 71.
87. Id. at 306.
88. Id. at 312.
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In addition, most products and new technologies are designed
for western agriculture systems, not for developing countries. "For
example, if Terminator genes enter the seed market, it will not be
possible for traditional or small farmers to use their plants to pro-
duce seeds."89 For this reason, peasant farmers and developing
countries have been protesting the development of Terminator
technology and pressing for the ban of these seeds." Rafael Alegria
of Via Campesina, an organization representing over 10 million
peasant farmers worldwide, declares, "Terminator is a direct assault
on farmers and indigenous cultures and on food sovereignty. It
threatens the well-being of all rural people, primarily the very poor-
est."91
For the organic farmer, too, the effects of GM crops could
prove detrimental. In addition to the negative implications of the
overuse of Bt by the biotechnology industry discussed above, or-
ganic farming could be impacted by direct contamination of organic
fields due to cross-pollination." Organic farmers are now struggling
to isolate their fields with only limited success and greater economic
costs because they need to leave fields uncultivated as a buffer. For
example, "a farmer may harvest 100 rows from the sides of non-
GMO fields to avoid cross-pollination and have additional costs for
travel to an elevator that handles non-GMO crops." '  Once con-
tamination has been detected, their crops are useless.95 In one inci-
dent, Bt corn cultivated in Texas contaminated the fields of a certi-
fied organic farmer.96 When Terra Prima, a Wisconsin food process-
ing company that had used the organic farmer's corn to make or-
ganic tortilla chips, detected traces of genetically engineered corn
through DNA testing, it had to destroy 87,000 bags of chips, worth
89. See Pimentel, supra note 50, at 63-64.
90. See, e.g., Press Release, Ban Terminator, UN Upholds Moratorium on Termi-
nator Seed Technology, Worldwide Movement of Farmers, Indigenous Peoples and
Civil Society Organizations Calls for Ban, March 31, 2006,
http://www.banterminator.org/news-updates/news-updates/un-upholds_morato
rium on terminator_seed-technology (last visited Aug. 15, 2007).
91. Ban Terminator, Introduction to Terminator Technology, http://www.banter-
minator.org/thejissues/introduction (last visited Aug. 17, 2007).
92. See Kolehmainen, supra note 38, at 280.
93. Id.
94. Grossman, supra note 35, at 222.
95. Kolehmainen, supra note 38, at 280.
96. See Anthony Shadid, Blown Profits Genetic Drift Affects More Than Biology-U.S.
Farmers Stand to Lose Millions from 'Genetic Drift' Phenomenon, BOSTON GLOBE, GI,
Apr. 8, 2001.
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over $ 150,000.17 Organic farmers may even lose their organic certi-
fication and face income loss during the years needed to be recerti-
fied as organic producers.98 Worse yet, if this contamination goes
undetected, these foods can cause potential harm to the consumers
who purchased the organic food precisely to avoid ingesting
GMOs-and without their knowledge and consent.
Despite the expectation that farmers and the hungry should be
the main beneficiaries of agricultural research, this technology is
controlled by the private sector with its development centered on
profitability." "By controlling germplasm from seed to sale, and by
forcing farmers to pay inflated prices for seed-chemical packages,
companies are determined to extract the most profit from their in-
vestment.""' ° Thus, the only real beneficiaries are the companies
with the capacity to use this genetic engineering in agriculture. '
As a result, many would conclude that the opportunity to direct
biotechnology to meet these lofty goals has been squandered (e.g.,
on the development of herbicide resistant plants engineered to sur-
vive the spraying of the company's own pesticides or Terminator
seeds that cannot reproduce, forcing these impoverished developing
countries to buy additional seeds from the manufacturer). More-
over, these largely unrealized benefits in fact may be outweighed by
the potential of new dangers to human health and the environment.
E. The Potential Risks
Unlike traditional pesticide use, which involves the application
of highly toxic chemicals to the outside of the plant in carefully
measured amounts so as not to kill the plant and can be washed off
the food by consumers, genetically engineered plants contain the
herbicide tolerance or pesticide resistance in every cell of the plant.
Thus, these toxins are unavoidably ingested by people, animals, and
beneficial insects. Although the effects on humans are as of yet un-
97. See id.
98. Grossman, supra note 35, at 222.
99. Altieri & Rosset, supra note 36 (citing SHELDON KRIMSKY & ROGER P. WRUBEL,
AGRICULTURAL BIOTECHNOLOGY AND THE ENVIRONMENT: SCIENCE, POLICY AND
SOCIAL IssuEs (1996)).
100. Id.
101. ChristianJ. Peters, Genetic Engineering in Agriculture: Who Stands to Benefit? 13
J. AGRIC. & ENVrL. ETHICS 313, 322-23 (2000).
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known, the deleterious effects on the monarch butterflies"°n and the
lacewings"°3 do not bode well for the future.
It should be noted that the process of creating GM plants dif-
fers from ordinary hybrids because it forces recombinations that do
not occur in nature, directly injecting genetic material to induce
traits that are not natural for the plant, for example, insect resis-
tance, herbicide resistance, or nut protein in a soybean to increase
protein content. In contrast, hybridization "works harmoniously
with superficial aspects of nature without fully disturbing the essen-
tial life force at the center of each cell."1°
Scientists have warned of the uncertainties and dangers inher-
ent in genetic engineering of food products and crops. In the in-
ternational community, the WHO study identified several risks pre-
sented by GMOs and GM foods to human health as part of its safety
assessment, including: "(a) direct health effects (toxicity); (b) ten-
dencies to provoke allergic reactions (allergenicity); (c) specific
components thought to have nutritional or toxic properties; (d) sta-
bility of the inserted gene; (e) nutritional effects associated with the
specific genetic modification; and (f) any unintended effects which
could result from the gene insertion.""°' In addition, GMOs gener-
ate risks to the environment such as unintended effects on non-
target organisms, ecosystems, and biodiversity, including heightened
development of resistant insects; outcrossing of transgenes; and
cross-contamination that may lead to genetically modified crops as
the dominant species."° Many of these risks have already become a
reality both in initial studies and alarming incidents. 7
102. John E. Losey, Linda S. Rayor, & Maureen E. Carter, Transgenic Pollen Harms
Monarch Larvae, 399 NATURE 214 (1999), available at http://www.biotech-
info.net/butterfliesbtcorn.html.
103. See A. Hilbeck et al., Effects of Transgenic BT Corn-Fed Prey on Mortality and
Development Time of Immature Chrysoperla carnea, 27 ENVrL. ENTOMOLOGY 480
(1998). See also Kolehmainen, supra note 38, at 285.
104. See Nathan Batalion, 50 Harmful Effects of Genetically Modified Food (2000),
http://www.cqs.com/50harm.htm (last visited Aug. 15, 2007). See also Ronnie
Cummins, Problems with Genetic Engineering 18 SYNTHESis/REGENERATION (1999),
available at http://www.greens.org/s-r/18/18-02.html (chronicling the dangers
associated with the insertion of "[a]nimal genes and even human genes into plants
or animals to create unimagined transgenic life forms").
105. WHO Study, supra note 31, at 12.
106. Id. at 20.
107. See Debra M. Strauss, Genetically Modfied Organisms in Food: A Model of Label-
ing and Monitoring With Positive Implications for International Trade, 40 LNT'L LAW. 95
(2006) [hereinafter Genetically Modified Organisms in Food] (providing a detailed
discussion of the risks and the mounting evidence).
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The amount that is unknown about genes significantly out-
weighs the amount that is known, prompting serious questions
about how much risk is too much and who should bear the burden
of this risk."°8 Since foods with GM ingredients are not identified,
American consumers are forced to accept the potential conse-
quences of these foods." In effect, U.S. citizens are the guinea pigs
in a grand experiment without their knowledge and consent because
these genetically altered foods are not labeled, segregated, or moni-
tored in the United States.110 Query, has the risk reached the level
where it has outweighed any potential benefit? Do individuals have
the right to determine their own fate?
The dangers to the ecosystem and biodiversity may return to
haunt the inventors; once the creation is let loose, it may spread
through the planet and become the dominant species. Since GMOs
are not currently segregated or labeled in the United States, and
their genetic mutations can mingle with natural species, if health
hazards are uncovered will it be too late to recall GM products from
the food chain? As a consequence, the outcome of man as the ulti-
mate conqueror of nature may be deeply disturbing. The WHO
study concludes that "[t]he risks of biotechnology, the problems of
interfering with nature, evolution and creation, and ethical consid-
erations are of increasing importance in the civil-society debate on
the development and introduction of GMOs.". The scientific
community has devised methods to handle disagreements over sci-
entific facts, but disagreements over the value and ethical compo-
nents of food-safety assessments are often much more difficult to
resolve.1 Yet discussions of the ethical implications are essential to
society's decision on how to proceed in this area.
III. THE ETHICAL ISSUES
To address from an ethical perspective the claims being made
in the ongoing debate about Genetically Modified Organisms
(GMOs), the Food and Agriculture Organization of the United Na-
tions (FAO) has formed an expert panel on ethics in food and agri-
108. See Kolehmainen, supra note 38, at 277.
109. Id.
110. See Strauss, Genetically Modified Organisms in Food, supra note 107 (comparing
U.S. law to the international law regulating GM foods).
111. WHO Study, supra note 31, at 56; see generally JANE MONTGOMERY &
SIVRAMIAH SHANTHARAM, BIOTECHNOLOGY, BIOSAFETY, AND BIODIVERSITY: SCIENTIFIC
AND ETHICAL ISSUES FOR SUSTAINABLE DEVELOPMENT (1999).
112. Id. at 57.
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culture."' The first report of the FAO panel, Ethical issues in food
and agriculture, introduces ethical questions related to its mandate,1
4
such as: What is the value of food? What is the value of human
health? What is the value of nature and natural resources? The
FAO panel identifies as values the right to adequate food, trust, op-
timization, informed consent and equity, in asserting that these
questions and ethical concerns are central to the debate about the
future."'
The FAO's second report, Genetically modified organisms, consum-
ers, food safety and the environment, highlights the role of ethical con-
siderations in food and agriculture, both in view of discussions on
GMOs and in relation to food safety and the environment."'6 Issues
discussed include ownership of the necessary tools to produce
GMOs, potential consequences of their use, and undesirable effects
that could result from their application, both now and in the fu-
ture."7 Above all, the report advocates the participation of all stake-
holders in making decisions regarding GMOs, emphasizing that
"[w]idely communicated, accurate and objective assessments of the
benefits and risks associated with the use of genetic technologies
should involve all stakeholders .... Experts have the ethical obliga-
tion to be proactive and to communicate in terms that can be un-
derstood by the lay person."
118
These economic and moral concerns have prompted the Euro-
pean Union (EU) and other countries to restrict the import of bio-
engineered foods or to require labeling of foods with genetically
modified (GM) ingredients."'9 The continued development of ge-
netically modified plants raises broad ethical issues, several of which
will be explored below: respect for nature and the value of life; con-
sideration of the environment; rights and responsibilities; equity,
113. For more information about the Food and Agriculture Organization (FAO),
see http://www.fao.org/ (last visited Aug. 15, 2007).
114. FAO, ETHICAL ISSUES IN FOOD AND AGRICULTURE (2001) [hereinafter FAO
REPORT 1], available at http://www.fao.org/DOCREP/003/X9601E/
X9601E00.HTM.
115. See id. See also WHO Study, supra note 31, at 56-57.
116. See FAO, FAO ETHICS SERIES 2: GENETICALLY MODIFIED ORGANISMS,
CONSUMERS, FOOD SAFETY AND THE ENVIRONMENT (2001) [hereinafter FAO REPORT
2], available at ftp://ftp.fao.org/docrep/fao/003/x9602e/x9602eOO.pdf.
117. Id.
118. Id. at25.
119. Farid E. Ahmed, Detection of Genetically Modified Organisms in Food, 20 TRENDS
BIOTECHNOLOGY 215 (2002). See also Strauss, Genetically Modified Organisms in Food,
supra note 107 (discussing international laws regarding GMOs).
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power, and the economically disadvantaged; and conflicts of interest
in public research.
A. Respect for Nature and the Value of Life
In the international community, the United Nations' Conven-
tion on Biological Diversity (CBD) recognizes the implicit value of
nature itself.2 ° The CBD by its terms embraces life, including "the
conservation of biological diversity" and "the sustainable use of its
components." l"' Thus, the CBD recognizes that "biological diversity
is about more than plants, animals and micro organisms and their
ecosystems-it is about people and our need for food security, medi-
cines, fresh air and water, shelter, and a clean and healthy environ-
ment in which to live.'"" In describing the CBD, the World Health
Organization (WHO) report observes, "[t]he summary of these ob-
jectives shows that all the main arguments usually discussed in a risk-
benefit evaluation of food biotechnology interfere with each other,
thus requiring a high level of ethical consideration." 3
In contrast to the principles of the CBD, the biotechnology in-
dustry, with its production of genetically engineered crops, reflects a
view of nature as objects to be manipulated and controlled with life
forms as commodities. One author recognizes that, despite this
consumerism, the United States "also share[s] an ethical commit-
ment to democracy, freedom and love for the land, however ma-
nipulated these ideas have been in the past."'24 He thus urges U.S.
citizens to question their blind allegiance to science fiction and
deepen their understanding of the integrity of the natural world. 5
The use of biotechnology on the cellular level to target agricul-
tural issues does not involve only science and the law, but raises
ethical and policy issues that strike at the very essence of life. Doing
120. See FAO REPORT 1, supra note 114; see also WHO Study, supra note 31, at 56.
The UN Convention on Biological Diversity (CBD) was adopted in Rio deJaneiro in
1992. See IISD Linkages, A Brief Introduction to the Convention on Biological Diversity,
http://www.iisd.ca/biodiv/cbdintro.html (last visited Aug. 15, 2007). The United
States signed the CBD but did not ratify it.
121. CBD, art. 1, available at http://www.biodiv.org/convention/arti-
cles.asp?lg=0&a=cbd-01.
122. CBD, About the CBD, http://www.biodiv.org/convention/default.shtml (last
visited Aug. 16, 2007).
123. WHO Study, supra note 31, at 56.
124. See Tokar, supra note 25.
125. See id.
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so should not be taken lightly without consideration of all of the
ramifications, recognizing that
[w]hen we start to alter the genetic composition of organisms, we take
into our own hands the instructions for life-instructions that have been
slowly and carefully evolving since the first appearance of life on this
planet, instructions that support the delicate balance of our ecosystem.
In assuming the immense responsibility to change those basic instruc-
tions, we must honestly and thoroughly analyze every possible motiva-
tion and ramification of this novel technology-not only environmental,
but social, political, ethical, and economic as well.1
2
6
The biotechnology industry acts on a drive to convert into a market-
able product all that is alive, altering the patterns of nature so as to
suit the whims of the commercial market. Genetic engineering con-
tradicts the unpredictability and freedom that is an inherent com-
ponent of life, to control that which cannot be the controlled. As a
result,
[n]othing in nature, from the bacteria that live deep within boiling hot
geysers to the molecules that form the human immune and reproductive
systems, would be immune from such exploitation and, where possible,
redesign. Biotechnology offers a way to continue ignoring underlying
problems, and perpetuates the myth that the inherent ecological limita-
tions of a nature-denying way of life can simply be engineered out of ex-
istence. 
2 7
In imposing a non-living model on nature, this use of technology
ignores critical values and reflects a lack of respect for life itself.
From an ethical perspective, Terminator seeds represent the
height of this folly--the biotechnology companies have taken away
the essential function of life to reproduce. In addition, this tech-
nology involves issues of ownership and the appropriateness of pat-
enting life forms.' Patenting genetic material is inherently prob-
126. MARTIN TEITEL & KIMBERLY WILSON, GENETICALLY ENGINEERED FOOD:
CHANGING THE NATURE OF NATURE: WHAT You NEED TO KNOW TO PROTECT
YOURSELF, YOUR FAMILY, AND YOUR PLANET 18 (1999).
127. Tokar, supra note 25. See also VANDANA SHIVA, BIOPIRACY: THE PLUNDER OF
NATURE AND KNOWLEDGE 24 (1997) (arguing that genetic engineering, far from
being socially useful, is "the ultimate expression of the commercialization of science
and the commodification of nature").
128. As a legal matter, the patenting of life has been permitted, commencing with
the U.S. Supreme Court decision in Diamond v. Chakrabarty, 447 U.S. 303 (1980),
which allowed a live organism (bacterium) to be patented. The availability of utility
patent protection for plants and seeds was confirmed in JE.M. Ag. Supply, Inc. v.
Pioneer Hi-Bred Int'l, Inc., 534 U.S. 124 (2001). As a result of this treatment by the
courts and U.S. Patent Office, biotechnology patents have proliferated.
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lematic as it also raises issues of social ethics."' Others have con-
cluded that allowing such monopolies through patents on genes
hampers scientific progress and is therefore not in the public inter-
est." For years, these companies have tried to control seeds and
their "new" creations as their property. Monsanto attracted atten-
tion in 1998 "with its aggressive prosecutions of farmers accused of
'pirating' its seed varieties" by following the traditional farming
practice of saving and replanting the company's (now patented)
seeds."' Rather than to continue to pursue these actions, the com-
panies have now developed a direct enforcement mechanism."' The
plants effectively self-destruct at the end of their cycle, by preventing
farmers-or nature-from continuing its innate course of germina-
tion to future generations.'
For these reasons, in 2000 the United Nations (UN) through the
CBD adopted a de facto moratorium on sterile seed technologies,
which it calls Genetic Use Restriction Technologies (GURTs).7 Ear-
lier this year, despite pressure from Canada, Australia, and New Zea-
land-"supported by the U.S. government and the biotechnology
industry"-the CBD upheld the international de facto moratorium
on Terminator technology."5  However, this UN ban has not
stopped the development of this technology or the support by other
129. See Keith Douglass Warner, Are Life Patents Ethical? Conflict Between Catholic
Social Teaching and Agricultural Biotechnology's Patent Regime, 14 J. AGRIC. & ENVTL.
ETHICS 301, 316 (2001), available at http://www2.ucsc.edu/cgirs/research/environ-
ment/afsrg/publications/Warner_- 2001.pdf (stating that "[t]he privatization of
germplasm formerly considered the common heritage of humankind is incompati-
ble with notions of the common good and economic justice"). See generally DONALD
BRUCE & ANN BRUCE, ENGINEERING GENESIS: THE ETHICS OF GENETIC ENGINEERING IN
NON-HUMAN SPECIES (1998); MARTIN TEITEL & HOPE SHAND, THE OWNERSHIP OF
LIFE: WHEN PATENTS AND VALUES CLASH (1997).
130. See WHO Study, supra note 31, at 55.
131. Tokar, supra note 25. See also Altieri & Rosset, supra note 36, at 156 (arguing
that "[b]y controlling germplasm from seed to sale, and by forcing farmers to pay
inflated prices for seed-chemical packages, companies are determined to extract the
most profit from their investment").
132. See generally Tokar, supra note 25.
133. Id.
134. Ban Terminator, The Campaign, http://www.banterminator.org/the-cam-
paign (last visited Aug. 17, 2007). See CBD, Agricultural Biodiversity Genetic Use Re-
striction Technologies (GURTs), http://www.biodiv.org/programmes/areas/agro/
gurts.aspx (last visited Aug. 17, 2007).
135. Ban Terminator, UN Upholds Moratorium, supra note 90.
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countries that continue to issue patents.'" Life continues to be
treated as an inert commodity.
B. Consideration of the Environment
Tampering with the genetic blueprints for life carries the possi-
bilities for enormous potential impact on the environment. As one
consumer advocate warns,
[n]o one has a crystal ball to see future consequences. Nevertheless,
alarm signals go off when a technology goes directly to the center of
every living cell-and under the guidance of a mechanical or non-living
way of restructuring or recreating nature. The potential harm can far
outweigh chemical pollution because chemistry only deals with things al-
tered by fire-or things that are not alive. 17
A farmer can use toxic chemicals and eventually convert the land
back to its natural state, perhaps for organic farming, after the
chemicals break down into natural chemicals in a matter of years. '
In contrast, with genetic pollution the alteration of the life in the
soil lasts forever."9 Farms may someday be blacklisted for having
once planted GM crops. As the acreage of GM plantings exponen-
tially expands, "the spreading potential impact on all ecosystems is
profound.""
The use of bioengineering in foods involves numerous threats
to the environment, particularly cross-pollination and lack of biodi-
versity, as discussed above. "[G]enetically engineered plants may be
more likely to exchange pollen with other plants than their non-
genetically engineered cousins" and "[g]enetic contamination of
neighboring crops has now been documented in the case of both
corn and rapeseed (canola).". The damaging effects of these trans-
genic plants on beneficial insects such as ladybugs and lacewings, as
well as the potential impact on other wildlife, should be taken into
136. Ban Terminator, Delta & Pine Land, developer of Terminator seeds, extends global
reach, supra note 24.
137. See Batalion, supra note 104. See also Ricarda Steinbrecher, What is Wrong
with Nature?, 18 SYNTHESIS/REGENERATION (1999), available at
http://www.greens.org/s-r/18/18-12.html (quoting a genetic scientist who argues,
"[a]t a time when our environment is already suffering extreme stress we should
avoid risking the fragile balance or compounding our problems with genetic engi-
neering").
138. See Batalion, supra note 104.
139. Id.
140. Id.
141. See Tokar, supra note 25.
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account when deciding whether genetic engineering is worth the
risk. Under the present analysis, the potential harm to human
health and the environment does not appear to be outweighed by
sufficient benefit.
42
Despite these initial misgivings, one commentator calls atten-
tion to that fact that the number of scientists studying the ecological
consequences of genetic engineering is far less than the multitudes
of researchers and technicians "who are employed to develop the
next generation of genetically engineered crop varieties."
4
In making determinations on how to proceed, policymakers
must consider the rights and responsibilities of all stakeholders-
farmers, consumers, the environment, and underprivileged popula-
tions-as well as the biotechnology industry. The environment is a
particularly vulnerable stakeholder, to whom we owe a special duty,
because it does not have the voice to defend itself from the med-
dling of mankind. One is reminded of the late Justice Douglas'
haunting dissent in Sierra Club v. Morton, when he lamented that
natural resources that "feel the destructive pressures of modern
technology and modern life" should have standing to sue for their
own protection "before these priceless bits of Americana (such as a
valley, an alpine meadow, a river, or a lake) are forever lost or are so
transformed as to be reduced to the eventual rubble of our urban
environment, the voice of the existing beneficiaries of these envi-
ronmental wonders should be heard.' "14
C. Rights and Responsibilities
Genetic modification of plants and the failure of the U.S. gov-
ernment to treat these crops and food products as different from
other foods raise critical ethical issues for consumers. " ' The nondis-
closure of the fact that their food was developed using bioengineer-
ing techniques removes the right of informed choice. This fails the
assessment from any ethical perspective, particularly a Kantian
model. U.S. citizens have been deprived of their autonomy and
freedom of choice, just as the farmers have been deprived of their
142. See, e.g., Kolehmainen, supra note 38, at 281. See generally GERHOLD K.
BECKER & JAMES P. BUCHANAN, CHANGING NATURE'S COURSE: THE ETHICAL
CHALLENGE OF BIOTECHNOLOGY (1996) (listing some environmental and ethical
considerations of genetically engineered plants and foods).
143. See Tokar, supra note 25.
144. Sierra Club v. Morton, 405 U.S. 727, 743, 750 (1972).
145. See generally Warner, supra note 129.
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independent livelihoods and the plants have been deprived of their
essence."'' Individuals have the fundamental right to know what
they are buying and eating, as well as the responsibility towards oth-
ers and the natural world.
An economic model also favors the disclosure of information.
47
According to this reasoning, "the market for GMOs at both the con-
sumer and producer level is unable to achieve a rational, efficient
and socially optimal result due to asymmetrical information. " '
Without adequate information, consumers cannot make rational
decisions about whether to purchase and consume GMOs, farmers
do not have the tools to negotiate with biotech seed producers, and
organic farmers cannot effectively allocate resources to protect their
crops from contamination by genetic drift.' 9 This market can only
function efficiently "if a mechanism is established for ensuring that
rational, scientifically-based information on the effects of GMOs on
human health, agricultural production, and the environment is
available to the public. Because transaction costs would be prohibi-
tively high for individual consumers or farmers to obtain such in-
formation, a system of mandatory disclosures tied to discretionary
participation in the market for GMOs should be established by the
government."'
The government has a responsibility to protect its citizens, par-
ticularly in such a critical area as the safety of the food supply.'1 As
a matter of ethics, the risks must not be placed on the unsuspecting
public rather than on the companies who have created these genetic
modifications.' To do so would also betray consumers' trust in
their government to ensure their health and well-being as fiduciaries
acting on their behalf.'3 The Food and Drug Administration (FDA)
has recognized this mandate in its regulatory approach to other ar-
eas of the food supply.'"
146. Tokar, supra note 25.
147. See Luke Brussel, Engineering a Solution to Market Failure: A Disclosure Regime
for Genetically Modified Organisms, 34 CUMB. L. REV. 427, 435 (2003-2004).
148. Id. at 430.
149. Id.
150. Id. at 432.
151. See, e.g., Debra M. Strauss, Reaffirming the Delaney Anticancer Clause: The Legal
and Policy Implications of an Administratively Created De Minimis Exception, 42 FOOD
DRUG COSM. L.J. 393, 426 (1987).
152. See id.
153. See id.
154. See id. at 423 (applying a zero risk policy to prohibit the introduction into the
food supply of food and color additives determined to cause cancer in laboratory
animals).
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Consumers have the right to choose what they eat, and in-
formed choice can only be realized through labeling.' According
to Consumers International, consumers' desires and opinions
should be respected due to a fundamental right to know and make
informed decisions." For example, a lack of labeling as to the pres-
ence of an introduced gene removes the individuals' right to avoid
known allergens and control their own fate. Eight percent of chil-
dren in the United States possess food allergies, some of which can
be fatal.' 7 When Pioneer Hi-Bred spliced Brazil nut genes into a
soybean to improve its protein content, the altered soybean pro-
voked severe allergic attacks in eight individuals sensitive to Bra~ll
nuts but not soybeans.' 8 Without a label alerting consumers that a
soybean could contain genes from a highly allergic nut, even indi-
viduals aware of their severe allergies would have no warning.'5
While the risks generate a need for labeling of the presence of
GMOs, such an approach is also necessitated above and beyond
safety issues, as a matter of taste and preference and for many
health-related reasons. It must be recognized that many consumers
make food choices based on religious, ethical, and environmental
considerations, for example, deciding not to eat veal, mass-produced
chickens, or non-organic produce. If biotechnology raises similar
ethical, health, and environmental concerns, it is not irrational for
people to act on these preferences and aversions to risk."n In order
to make these informed decisions, food products must be compre-
hensively labeled. As a matter of ethics and public policy, "[s]ince
labeling laws are created to meet consumer needs, consumer opin-
ion should be respected."'
155. Jean Halloran & Michael Hansen, Why We Need Labeling of Genetically Engi-
neered Food, 18 SYNTHESIS/REGENERATION (Winter 1999), available at
http://www.greens.org/s-r/ 18/18-07.html.
156. Id.
157. Kolehmainen, supra note 38, at 278.
158. Julie A. Nordlee et al., Identification of a Brazil Nut Allergen in Transgenic Soy-
beans, 334 NEw ENG.J. MED. 688 (1996).
159. "About twenty-five percent of Americans have adverse reactions to foods.
Eight percent of children and two percent of adults have food allergies as tested by
blood immunoglobins." Batalion, supra note 104. Some "individuals... are so aller-
gic to [the Brazil] nut, they go into apoplectic shock (similar to a severe bee sting
reaction), which can cause death." Id. See also Marion Nestle, Allergies to Transgenic
Foods: Questions of Policy, 334 NEw ENG.J. MED. 726 (1996).
160. TEITEL & WILSON, supra note 126, at 68. See also Halloran & Hansen, supra
note 155.
161. Halloran & Hansen, supra note 155.
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The decision to allow the public to consume unlabeled geneti-
cally engineered food strikes some people as "grossly undemocratic
and slanted too far in favor of corporate interests."'62 "Should our
society allow the purported commercial rights of a corporation to
supersede the citizen's right to make informed decisions in the mar-
ketplace?"'63 Every person has a right to make choices about what
they eat. Every person has a right to know. "
For consumers who are sensitive about the content of the food
they eat, eating organic foods may be a choice they can make, but it
is not a workable and equitable solution for the masses. Organic
foods tend to be more expensive than non-organic products and
they are not available for all foods, stores, and areas of the country.
Thus, most consumers do not have the true choice to purchase or-
ganic foods as an alternative to what has previously been known as
"traditional" foods. Moreover, issues of cross-contamination in-
creasingly threaten the integrity and economic viability of the or-
ganic food supply. 5
The government has the ethical obligation to protect the safety
of the mainstream food supply for all of its citizens. The FAO ex-
pert panel on ethics recognized that
[t]he right to adequate food, as understood today, carries with it obliga-
tions on the part of states to protect individuals' autonomy and capacity
to participate in public decision-making fora, especially when other par-
ticipants are more powerful, assertive or aggressive. These obligations
can include the provision of public resources to ensure that those fora
take place in a spirit of fairness and justice. ' 66
The FAO report concluded that this right has not been fulfilled in
connection with genetically engineered products.'67 The most im-
portant stakeholders have been excluded from the process because
[c]itizens have a direct interest in technological developments, yet there
are obstacles to their participation in decision-making that must be ac-
knowledged and overcome. The public has not been adequately in-
formed about the application of gene technology to food production or
162. TEnELL& WILSON, supra note 126, at 61.
163. Id.
164. Id. at 73. See also Gerad Middendorf, Mike Skladany, Elizabeth Ransom &
Lawrence Busch, New Agricultural Biotechnologies: The Struggle for Democratic Choice,
50 MONTHLY REV. 85 (1998).
165. WHO Study, supra note 31, at 53 (citing Codex Alimentarius Commission,
Guidelines for the Production, Processing Labeling and Marketing of Organically Produced
Foods, available at http://www.fao.org/organicag/doc/glorganicfinal.pdf).
166. FAO REPORT 2, supra note 116.
167. See id. at 25-26.
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the consequent potential impacts on consumers' health and the envi-
168
ronment.
As a result, with the confusing and conflicting jumble of claims in
the media, "the public is losing faith in scientists and government.""
Following similar reasoning, Geoffrey Podger, the Executive Di-
rector of the European Food Safety Authority (EFSA), favors a label-
ing approach as a means to regaining the support of the public.7'
He explains that the European opposition to GMOs was based on
ethical grounds as a reaction to being denied a choice when GMO
and non-GMO varieties could not be differentiated. 7' Thus, the
European regulatory approach arose in part as a solution to this
ethical and practical duty to inform. The advantage of labeling is
that it provides a choice "[a]nd while the people who insist on
choice may be quite a small part of the population, they are very
vociferous and they are often in positions of power and promi-
nence."'" Accordingly, the key to public perceptions is a transpar-
ent regulatory process that gives people all available information on
the science.73
In the United States, the public outrage at being denied a
choice has generated a grassroots political effort to raise conscious-
ness of consumers and alert them as to what they are not being told,
while advocating labeling. 4 New legislative efforts attempt to re-
spond to the public's right to know, as well as the safety concerns
for consumers and farmers. On May 2, 2006, Representative Dennis
Kucinich (Democrat-Ohio) introduced the "Genetically Engineered
Food Safety Act" and four other bills regarding GMOs. 7'
168. Id. at 25.
169. Id.
170. Geoffrey Podger, European Food Safety Authority Will Focus on Science, 5 EUR.
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Most important is the responsibility of government to protect
its citizens and respond to their concerns. This moral imperative
would suggest mandatory labeling and monitoring of, and possibly a
moratorium on, the use of GMOs in food. '76 Unlike the Europeans,
U.S. citizens trust their government and regulatory agencies. 7 This
fact offers an even greater reason why it is critical that the govern-
ment does not betray that trust.
D. Equity, Power, and the Economically Disadvantaged
Any exploration of ethical issues should include consideration
of equity, distributive justice, and the greater good. Of particular
interest are two of the questions adopted by the Rotary Club as part
of their statement of business ethics: "[i]s it fair to all concerned?"
and "[w]ill it be beneficial to all concerned?"78
Contrary to these ethical principles, the story of biotechnology
in food has become a matter of corporate control. "A small number
of powerful transnational companies have come to increasingly
dominate the fields of seed production, agricultural chemicals and
pharmaceuticals."' According to the Action Group on Erosion,
Technology and Concentration (ETC Group), the top ten multina-
tional seed firms control half of the world's commercial seed sales (a
total worldwide market of approximately $21 billion per year).' "
Corporate control and ownership of seeds-the first link in the food
chain-has far-reaching implications for global food security. Sophia
Kolehmainen, Director of Programs at the Council for Responsible
Genetics, explains that
[a] small number of corporations are taking legal and physical control
over the world's food supply, thereby decreasing biodiversity while
2007). See also Strauss, International Regulation of Genetically Modified Organisms,
supra note 12, at 186-87 (describing these bills the last time they were introduced by
Rep. Kucinich in May 2002).
176. For more on the proposals for a regulatory response, see Strauss, Interna-
tional Regulation of Genetically Modified Organisms, supra note 12.
177. George Gaskell et al., Worlds Apart? The Reception of Genetically Modified Foods
in Europe and the U.S., 285 Sci. 384 (1999) (describing an attitudinal study analyzing
public perceptions of biotechnology, together with press coverage and policy for-
mation).
178. Rotary International, About Rotary, http://www.rotary.org/aboutrotary/
4way.html (last visited August 21, 2007).
179. Tokar, supra note 25.
180. ETC Group Communiqu6, Global Seed Industry Concentration-2005,
Sept./Oct. 2005, Issue #90, available at http://www.etcgroup.org/upload/publca-
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[VOL. 3:1
2007] ETHICAL IMPLICATIONS OF GENETICALLY MODIFIED PLANTS 31
working within systems of food ownership at the genetic level. The is-
sues of patents on living organisms, ag-biotech monopolies, and the
creation of monocultures all raise serious questions about the soundness
of genetically engineering the world's food supply.
181
The prevalence of large monopolies in the seed and chemical indus-
try threatens to exclude the voices of farmers and consumers from
the debate about genetically engineering food. This scenario is un-
wise for ethical and public policy reasons, as "[r]elying on a handful
of self-interested corporations to make important and far-reaching
decisions about agriculture and food cannot possibly result in equi-
table policies, because genetic engineering threatens even the small
organic farmer with risks of genetic drift and genetic pollution.""
For example, the creation of monocultures by biotechnology com-
panies precludes the natural diversity that plants need to survive."
Given that the control of seeds and agricultural research is held in
fewer hands-with the power and priority of protecting their finan-
cial interests in the technology-the world's food supply is "increas-
ingly vulnerable to the whims of market maneuvers.""
The use of Terminator technology raises issues of equity as well,
because it makes farmers dependent on biotech companies and
takes away their livelihoods, preventing them from regenerating
their plants from year to year." The latter is particularly ironic for
developing countries, adding a financial burden to an impoverished
country that biotechnology was supposed to help-one of the origi-
nal justifications for its development. The agrochemical industry
has been increasingly usurping the choices that farmers make each
year about that season's crops, from the systematic patenting of
plant varieties, to the restricting of crops and usage of pesticides
under contract." With the Terminator, the self-destruct mechanism
embedded in each plant has achieved the ultimate in corporate con-
trol of these natural resources.
As discussed earlier, unequal access and ability to pay for or-
ganic foods prevents this source from being a viable alternative for
the masses. Moreover, in view of the dangers of cross-
181. Kolehmainen, supra note 38, at 282.
182. Id. at 283.
183. A classic example of the dangers of monocultures was seen in the 1845 Irish
Potato Famine. Id.
184. Seed Industry Concentration, supra note 180. See also LAWRENCE BUSCH ET AL.,
PLANTS, POWER AND PROFIT: SOCIAL, ECONOMIC AND ETHICAL CONSEQUENCES OF THE
NEW BIOTECHNOLOGIES (1992).
185. See Tokar, supra note 25.
186. Id.
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contamination, organic fields cannot be relied upon as a solution to
the security of the food supply in the long run.
Similarly, specialized equity concerns come into consideration
with respect to economically disadvantaged countries, raising issues
such as distributive justice, fairness, utility, and competing values
systems. Developing countries who have access to natural resources
often find the benefits diverted to the companies who possess the
technology, distribution, and control. A group of experts at a
roundtable on the ethics of biotechnology posed the question,
"[h]ow can we foster collaborations with countries that have natural
resources that may benefit all countries through technological de-
velopment and provide a fair return to the country of origin?"187 In
the international realm, the principles of the CBD provide that, in
addition to the conservation of biological diversity and the sustain-
able use of its components, countries should promote "the fair and
equitable sharing of the benefits derived from utilization of genetic
resources."'" If in fact benefits come from biotechnology products
that are derived from a country's natural resources, "how much of
that value should fairly be shared?" "
E. Conflicts of Interest in Public Research
Many people have expressed concern that the academic com-
munity involved in research is predominantly tied to the industries
and the patents they seek to develop."' This direct financial stake,
via stock options or patent participation, creates an inherent conflict
of interest. One fear is that "the lure of profit could color scientific
integrity, promoting researchers to withhold information about po-
tentially dangerous side-effects." 9'
Well-funded programs in plant genetics and genetic engineer-
ing are supplanting research to enhance organic methods and other
low-input alternatives. A 1990 study discovered that "from [ten per-
cent] up to one third of biomedical researchers at prestigious uni-
187. Diane E. Hoffman & Lawrence Sung, Symposium Report: Future Public Policy
and Ethical Issues Facing the Agricultural and Microbial Genomics Sectors of the Biotech-
nology Industry, 24 BIOTECH. L. REP. 10, 25 (2005) (roundtable discussion by experts
of the most significant public policy and ethical issues that will emerge as a result of
biotechnology).
188. CBD, art. 1., Objecive, available at http://www.biodiv.org/convention/arti-
cles.asp?lg=0&a=cbd-01.
189. Hoffman & Sung, supra note 187, at 23.
190. Id. at 12-13.
191. Batalion, supra note 104.
[VOL. 3:1
2007] ETHICAL IMPLICATIONS OF GENETICALLY MODIFIED PLANTS 33
versities such as Stanford and MIT had direct corporate ties. '""
With the exponential growth of the biotechnology industry since
then, today's figures are no doubt even higher. Will this connection
continue to divert more public funds to support the research agenda
of the biotechnology industry?19" '
Some groups have also raised the issue of intellectual property
practices as restricting the development of new genetically engi-
neered crops. In July 2003, a coalition of public sector research in-
stitutions announced the formation of the Public-Sector Intellectual
Property Resource for Agriculture (PIPRA).'" PIPRA, which is
funded by the Rockefeller and McKnight Foundations, argues that
"the benefits of much publicly funded research come to private in-
dustry through university technology transfer programs, limiting
universities' flexibility to conduct research.""95 The concern is that
biotechnology patents will not be applied to developments with little
commercial value that would benefit the poor.'" Perhaps this is one
reason the original goal of food security has not materialized.
Because the research at public institutions is often heavily influ-
enced by the source of funding for these projects, this predomi-
nantly private funding has diverted research time and money away
from projects that would benefit "the public good, such as biological
control, organic production systems and general agroecological
techniques." '97 This problem has prompted calls that "[c]ivil society
must request more research on alternatives to biotechnology by uni-
versities and other public organizations." '98
IV. AN ETHICAL PROPOSAL
Upon an examination of the issues discussed above, it becomes
apparent that ethical principles should shape the solution of the
future of biotechnology food products. Such a resolution should
include a plan to: (1) involve all stakeholders-farmers, consumers,
192. Tokar, supra note 25.
193. Id.
194. Richard C. Atkinson et al., Public Sector Collaboration for Agricultural IP Man-
agement, 301 Sci. 174 (2003). See also Public Sector Intellectual Property Resource
for Agriculture (PIPRA), http://www.pipra.org/ (last visited Aug. 21, 2007).
195. Hoffman & Sung, supra note 187, at 15.
196. Id.
197. Altieri & Rosset, supra note 36 (citing SHELDON KRIMPSKY & ROGER P.
WRUBEL, AGRICULTURAL BIOTECHNOLOGY AND THE ENVIRONMENT: SCIENCE, POLICY
AND SOCIAL ISSUES (1996)).
198. Id
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the environment, and underprivileged populations, as well as the
biotechnology industry; (2) inform them on the science, including
all potential and discovered risks to human health and the environ-
ment; (3) require comprehensive labeling, which is necessary for
informed consumer choice; and (4) promote more active and inde-
pendent involvement of regulatory agencies vis4-vis the biotechnol-
ogy companies.
The biotechnology companies have usurped the function of
government and streamlined Genetically Modified Organisms
(GMOs) into production without including the full scientific com-
munity, the public, and underrepresented stakeholders such as de-
veloping countries, the small farmers, and the environment. The
government must reassert its duty to protect the public by adopting
a more cautious approach with greater weight on safety concerns.
At this point, labeling as to the use of GMOs or genetically modified
(GM) processes is essential. But "labeling must not take away the
responsibility of authorities for risk assessment and decision-
making.""n This should include, at the very least, segregation of GM
products, monitoring and pre- and post-market safety assessments. °"
If warranted after a full investigation into the scientific, legal, and
ethical ramifications, society may ultimately decide to severely re-
strict or ban GMOs in food. Most importantly, all participants
should be wary not to be blinded by a brilliant but unfulfilled prom-
ise.
The future of biotechnology depends in large measure on ap-
propriate public education on both the science and the ethics to
allow consumers to reach an informed opinion. In the past, the in-
dustry has learned that public perceptions, in Europe for example,
can have a detrimental effect on their acceptance and on interna-
tional trade." ' Accordingly, there must be public involvement in,
and a forum for, legal and ethical issues with the realization that
"[fWrom this collective knowledge, balanced public policies will be
possible.""'2
It is significant to note that the roundtable on ethics in biotech-
nology identified as a top priority the "need for common regula-
tions regarding labeling and risk reduction across international bor-
ders so that new GM products can be imported and exported with
199. WHO Study, supra note 31, at 54.
200. See Strauss, International Regulation of Genetically Modified Organisms, supra
note 12, at 191.
201. Hoffman & Sung, supra note 187, at 24.
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assurance that the products meet global standards of safety." °3 The
global nature of the technology prompted a consideration of the
harmonization of laws in the international community regarding
intellectual property, public health and safety regulations, and natu-
ral resource and expertise disparities. '  In addition, scientists
should be encouraged to carry out research relevant to helping de-
veloping countries with new technologies.
The World Health Organization (WHO) study also recognized
the need and responsibility for communicating risks to the public so
that "ethical components of food-safety decisions are clearly identi-
fied as early in the process as possible" and "value-laden choices
made by risk managers are made in an open, participatory process
that respects the fights and roles of all stakeholders."" The report
by the Food and Agriculture Organization (FAO) of the United Na-
tions concluded that "a strategy that is more sensitive to ethical is-
sues should make food-safety risk analysis more effective, by making
decisions sounder, more transparent, more democratic and better
understood. This, in turn, should make risk-analysis decisions more
acceptable to and useful for the governments and citizens of all na-
tions."" °'
V. CONCLUSION
From an ethical perspective, the problem is not that this tech-
nology exists, but how that technology is being used. This article
has raised for discussion some important issues to consider as to
ethical dimensions of the technology and how it is being utilized. Is
it being applied towards the greater good? Are genetically modified
(GM) plants being cultivated to produce food for the masses, or to
create profits for a company whose seeds have been genetically
modified to require purchase every year and not regenerate as
farmers have done for centuries in order to make their living? Are
GM plants being used to help the environment, or is there a greater
203. Id. at 27; see also Strauss, Genetically Modified Organisms in Food, supra note
107.
204. See id.
205. Id. The participants observed that the cost-benefit analysis for each type of
technology is very different. For example, a GM product like Golden Rice to ad-
dress vitamin A deficiency would be considered more cost effective than Roundup
Ready® soybeans, which are not positioned as the solution to world hunger.
Hoffman & Sung, supra note 187, at 23-24.
206. WHO Study, supra note 31, at 56 (citing FAO REORT 1, supra note 114).
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potential for harm to human health and the environment? And do
the current regulations or lack thereof violate our responsibilities to
others by not allowing them a choice as to whether they knowingly
and willingly assume the risks of ingesting these GM substances?
If anything, this new technology should be used to assist less-
developed nations, rather than to further the disparities in natural
resources and technical expertise between the United States and
economically developing countries. Accordingly, research should be
directed towards eliminating world hunger and lowering the barri-
ers to food distribution. While the development of Golden Rice is
certainly preferable as an ethical matter to Roundup Ready® crops,
note that this justification for bioengineered food has been revealed
to be flawed, as an oversimplification of the problems of world hun-
ger, vitamin deficiencies, and more complex social issues. Biotech-
nology should not be used to divert important resources from re-
searching and applying more sustainable solutions for world food
security.
Raising global concerns, the World Health Organization
(WHO) study concluded that there is a need to discover opportuni-
ties where biotechnology can contribute to the secure generation of
nutritious foods in keeping with regional needs, recognizing that
"[s]uch opportunities should be based on sustainable food produc-
tion preserving biodiversity and respecting the values of nature,
while taking into consideration ethical objectives and social equity in
respect to regional conditions, needs and wants.""0 8 Thus, a secure
future would encompass a respect for nature and the value of life,
consideration of the environment, rights and responsibilities of all
stakeholders, equity, and distributive justice. As proposed above,
fully informing the public and transparency in the regulatory proc-
ess are key.
The ethical implications are clear, followed by the expectation
that the legal system will fill in the ethical gap as it has done in so
many other areas and, at the very least, require labeling, pre-market
approval, and monitoring of Genetically Modified Organisms
(GMOs) in food products and ingredients. EU law takes into ac-
count ethical issues."° It is morally imperative for U.S. law to do so
208. Id. at 59.
209. See, e.g., Council Directive 2001/18/EC, 2001 O.J. (L106), available at
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[VOL. 3:1
2007] ETHICAL IMPLICATIONS OF GENETICALLY MODIFIED PLANTS 37
as well. The government must fulfill its responsibility to protect its
citizens, respond to their concerns, and not betray their trust by
forcing them to bear the risk of GMOs without informed consent.
As one scholar has queried, "[w]ill we be able to make ethical
choices about what is humanly desirable, or will society become
progressively more enslaved to the 'free-market' dictum that what-
ever can be done will be done?" °10
Some opponents of genetically modified foods have labeled
them "Frankenfoods." "' The origins of this analogy, as a reaction to
the proliferation of untested technology with consequences that are
as yet unknown, cannot easily be dismissed. Perhaps policymakers
should heed the advice of that classic moral: "Learn from me, if not
by my precepts, at least by my example, how dangerous is the ac-
quirement of knowledge, and how much happier that man is who
believes his native town to be the world, than he who aspires to be-
come greater than his nature will allow." 12 Fundamentally, geneti-
cally modified plants substitute human wisdom for the wisdom of
nature."' Our society has yet to address the ultimate issue, particu-
larly with regard to Terminator seeds-should mankind be usurping
the basic functions of life?
porting on ethical issues and the involvement of the public in the authorisation
process").
210. Tokar, supra note 25.
211. John S. Applegate, The Prometheus Principle: Using the Precautionary Principle to
Harmonize the Regulation of Genetically Modified Organism, 9 IND. J. GLOBAL LEGAL
STuD. 207, 209-12 (2001).
212. Id. at 212 (citing MARY SHELLEY, FRANKENSTEIN, OR, THE MODERN
PROMETHEUS, at 56 (Airmont Publishing Co. 1963) (1817)).
213. Id. at 211-13.

